These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2079074)

  • 21. Septo-optic dysplasia.
    Brook CG; Sanders MD; Hoare RD
    Br Med J; 1972 Sep; 3(5830):811-3. PubMed ID: 5076259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
    Ghigo E; Imperiale E; Boffano GM; Mazza E; Bellone J; Arvat E; Procopio M; Goffi S; Barreca A; Chiabotto P
    J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Septo-optic dysplasia.
    Ferran Kd; Paiva IA; Gilban DL; Resende M; Souza MA; Beserra IC; Guimarães MM
    Arq Neuropsiquiatr; 2010 Jun; 68(3):400-5. PubMed ID: 20602044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone-releasing hormone: studies in normal subjects and patients with disorders of growth hormone secretion.
    Ross RJ; Grossman A
    Pediatrician; 1987; 14(3):138-45. PubMed ID: 3134650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic growth hormone-releasing hormone (GHRH 1-44) in the differential diagnosis between hypothalamic and pituitary GH deficiency.
    Bozzola M; Tatò L; Cisternino M; Nava C; Valtorta A; Chiesa M; Severi F; Gaburro D
    J Endocrinol Invest; 1986 Dec; 9(6):503-6. PubMed ID: 3106460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormone.
    Ogilvy-Stuart AL; Stirling HF; Kelnar CJ; Savage MO; Dunger DB; Buckler JM; Shalet SM
    Clin Endocrinol (Oxf); 1997 May; 46(5):571-8. PubMed ID: 9231053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Septo-optic dysplasia and growth hormone deficiency. De Morsier-syndrome (author's transl)].
    Frisch H; Schober E
    Monatsschr Kinderheilkd (1902); 1980 Jan; 128(1):50-2. PubMed ID: 6102348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of growth hormone (GH)-releasing hormone (GRH) on plasma GH in relation to magnitude and duration of GH deficiency in 26 children and adults with isolated GH deficiency or multiple pituitary hormone deficiencies: evidence for hypothalamic GRH deficiency.
    Schriock EA; Lustig RH; Rosenthal SM; Kaplan SL; Grumbach MM
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1043-9. PubMed ID: 6427257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypothalamic-pituitary function in children with optic nerve hypoplasia.
    Costin G; Murphree AL
    Am J Dis Child; 1985 Mar; 139(3):249-54. PubMed ID: 2983530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone-releasing activity of growth hormone-releasing peptide-1 (a synthetic heptapeptide) in children and adolescents.
    Laron Z; Bowers CY; Hirsch D; Almonte AS; Pelz M; Keret R; Gil-Ad I
    Acta Endocrinol (Copenh); 1993 Nov; 129(5):424-6. PubMed ID: 8279223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebral midline developmental anomalies: endocrine, neuroradiographic and ophthalmological features.
    Antonini SR; Grecco Filho A; Elias LL; Moreira AC; Castro M
    J Pediatr Endocrinol Metab; 2002; 15(9):1525-30. PubMed ID: 12503860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response to growth hormone-releasing hormone as evidence of hypothalamic defect in optic nerve hypoplasia.
    Leaf AA; Ross RJ; Jones RB; Besser GM; Savage MO
    Acta Paediatr Scand; 1989 May; 78(3):436-9. PubMed ID: 2545075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spectrum of clinical presentations and endocrinological findings of patients with septo-optic dysplasia: a retrospective study.
    Cemeroglu AP; Coulas T; Kleis L
    J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):1057-63. PubMed ID: 25879316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of septo-optic dysplasia.
    Fukushima N; Konno M; Sato T; Nohara Y; Matsuura N
    Tohoku J Exp Med; 1978 Oct; 126(2):193-7. PubMed ID: 102048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone-releasing hormone: therapeutic perspectives.
    Gelato MC; Malozowski S; Pescovitz OH; Cassorla F; Loriaux DL; Merriam GR
    Pediatrician; 1987; 14(3):162-7. PubMed ID: 3134651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolving hypopituitarism in children with central nervous system lesions.
    Hanna CE; LaFranchi SH
    Pediatrics; 1983 Jul; 72(1):65-70. PubMed ID: 6408595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypothalamic defects in two adult patients with septo-optic dysplasia.
    Lam KS; Wang C; Ma JT; Leung SP; Yeung RT
    Acta Endocrinol (Copenh); 1986 Jul; 112(3):305-9. PubMed ID: 3751451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The usefulness of the GHRH stimulation test in the diagnostics of growth hormone deficiency in children.
    Obara-Moszyńska M; Niedziela M
    Endokrynol Pol; 2015; 66(2):137-41. PubMed ID: 25931044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repetitive injections of growth hormone releasing hormone (GHRH1-44) to normal volunteers and patients with growth hormone deficiency.
    Hümmelink R; Sippell WG
    Horm Metab Res; 1990 Feb; 22(2):101-8. PubMed ID: 2182500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Onset of pituitary hormone deficiencies in optic nerve hypoplasia: a temporal trend analysis of 32 children at Mayo Clinic.
    Wadams HD; Gupta N; Novotny P; Tebben PJ
    J Pediatr Endocrinol Metab; 2020 Jan; 33(1):139-145. PubMed ID: 31811804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.